Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

0
Player Avatar pchop123 (79.82) Submitted: 1/9/2013 9:15:03 PM : Outperform Start Price: $3.43 SVA Score: -5.23

Outstanding buying opportunity

Featured Broker Partners


Advertisement